article information

Anesthesiology and Pain Medicine: Vol.2, issue 1; e93341
published online: July 10, 2012
article type: Review Article
received: May 11, 2019
accepted: May 20, 2012
DOI: https://doi.org/10.5812/aapm.6286
Crossmark

Beyond Beauty: Onobotulinumtoxin A (BOTOX®) and the Management of Migraine Headaches

authors:

avatar Devra Becker 1 , avatar Bardia Amirlak 2 , *

Department of Plastic and Reconstructive Surgery, Case Western University, Cleveland, USA
Department of Plastic and Reconstructive Surgery, University of Texas Southwestern Medical Center, Dallas, USA

how to cite: Becker D, Amirlak B. Beyond Beauty: Onobotulinumtoxin A (BOTOX®) and the Management of Migraine Headaches. Anesth Pain Med. 2012;2(1):e93341. https://doi.org/10.5812/aapm.6286.

Abstract

Based on the conducted anatomic studies at our institutions as well as clinical experience with migraine surgery, we have refined our onobotulinumtoxin A (BOTOX®) injection techniques. Pain management physicians are in unique position to be able to not only treat migraine patient, but also to be able to collaborate with neurologists and peripheral nerve surgeons in identifying the migraine trigger sites prior to surgical deactivation. The constellation of migraine symptoms that aid in identifying the migraine trigger sites, the potential pathophysiology of each trigger site, the effective methods of botulinumtoxin and nerve block injection for diagnostic and treatment purposes, as well as the pitfalls and potential complications, will be addressed and discussed in this paper.

Fulltext

References

  • 1.

    The references are available in PDF file.